Skip to main content
. 2019 Dec 6;49:183–186. doi: 10.1016/j.breast.2019.12.001

Table 1.

ST2 levels at the different time points for the entire study population (n = 63).

Baseline
After RT
3 years
p1 p2
Md (IQR) Md (IQR) Md (IQR)
ST2 (ng/ml) 17.9 (12.4–22.4) 18.2 (14.1–23.5) 18.7 (15.8–24.2) 0.075 0.018

RT, radiotherapy; Md, median; IQR, interquartile range; p1, change from baseline to after RT; p2, change from baseline to the three-year follow-up.

Statistical significance is shown in bold (p < 0.05).